Announcements Trials
Browse Landscape

Status

Recruiting 2Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 9Observational 4

Sponsor

Cancer Type

Thoracic 1Lymphoid 1Breast 1

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Interventions

Selective Serotonin Reuptake Inhibitors 1Antidepressive Agents, Tricyclic 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Depressive Disorder × Clear all
NCT07363980 2026-02-03

COTIRA

University of Aarhus

Enrolling by invitation
4,000 enrolled
Thoracic

Anxiety Disorders, Arthritis, Rheumatoid, Cardiovascular Diseases, Depressive Disorder, Disease, Lung Diseases, Lung Neoplasms, Respiration Disorders, Pulmonary Disease, Chronic Obstructive

NCT07290153 2025-12-18

SCHBCC-N0105

Fudan University

Recruiting
120 enrolled
Breast

Generalized Anxiety Disorder, Breast Neoplasms, Depressive Disorder

NCT06396312 2025-05-09

DECIDE

Max-Planck-Institute of Psychiatry

Recruiting
130 enrolled
Lymphoid

Depressive Disorder, Major, Depressive Disorder, Lymphoma, Follicular, Recurrence

NCT01077596 2017-05-30

Carcinogenicity Study of Bupropion

GlaxoSmithKline

Completed
50,430 enrolled 23 charts

Depressive Disorder, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡